Trial intelligence / Profile preview

MW189 in Intracerebral Hemorrhage (BEACH)

NCT05020535Phase 2Active, not recruiting

Sponsor
Johns Hopkins University
Start
Oct 2022
Primary completion
Nov 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of MW189 in intracerebral hemorrhage (ICH), sponsored by Johns Hopkins University. Started Oct 2022; status: active, not recruiting.

02

Drugs

MW189
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on NCT05020535.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05020535.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call